- Village Hotel Changi, Singapore
June 20 to 22, 2025 - +1-571-5561014
diabetes@precisionglobalconferences.com
scientific Sessions
Emerging Pathways in Type 1 Diabetes Immunotherapy
Description: Experts will update the latest developments in immunotherapy for Type 1 diabetes at the Diabetes and Endocrinology World Conference, discussing the most updated research and clinical trials that will change the management of this autoimmune condition. The emerging pathways in T1D immunotherapy are focused on immune modulation to stop or reverse the autoimmune attack on the insulin-producing beta cells. Recent studies have investigated strategies involving immune checkpoint inhibitors, anti-inflammatory agents, and immunomodulatory drugs that act on specific T-cell responses responsible for beta-cell destruction. Moreover, cellular therapies involving regulatory T-cell infusions and stem cell-based regeneration techniques are highly promising in restoring immune tolerance and insulin production. Developing these newer strategies focuses on the provision of management, but hopefully a cure, of T1D.
Related Sessions
Don't miss our future updates!